Home > Healthcare > Medical Devices > Implantable Devices > cardiac prosthetic devices market
Get a free sample of Cardiac Prosthetic Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Cardiac Prosthetic Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market is highly competitive, with major players like Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences Corporation, and Biotronik leading the market. These companies focus on innovation, with advancements in minimally invasive procedures and device technologies such as leadless pacemakers and transcatheter heart valves. Intense competition exists due to the presence of both global and regional manufacturers, driving the continuous development of advanced, cost-effective devices.
Prominent players operating in the cardiac prosthetic devices industry include:
Key players in the industry include Abbott Laboratories, Abiomed, AtriCure, Biotronik, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Labcor Laborat
The North America cardiac prosthetic devices market recorded USD 3.7 billion in 2024 and is anticipated to grow at a CAGR of 7.7% between 2025 and 2034, led by a high burden of cardiovascular diseases and contributing lifestyle factors.
The pacemaker segment generated USD 5.7 million in 2024, driven by the rising incidence of arrhythmias, including bradycardia, atrial fibrillation, and heart block.
The global cardiac prosthetic devices industry was valued at USD 8.6 billion in 2024 and is expected to grow at a CAGR of 8.4% from 2025 to 2034, driven by continuous technological advancements in medical devices.